Ovoca Bio reported 1.83 in PE Price to Earnings for its fiscal semester ending in June of 2024.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
ALKERMES 39.33 19.8 Mar/2026
Dianthus Therapeutics 3.8 1.53 Sep/2024
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 19.37 7.21 Mar/2026
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Organon & Co 3.75 0.87 Dec/2025
Ovoca Bio 1.83 3.29 Jun/2024
Revvity 30.79 19.08 Mar/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 14.61 4.21 Mar/2026